Related Experiment Video
Updated: Feb 9, 2026
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis
Marilena Tauro1, Conor C Lynch2
1Department of Tumor Biology, H. Lee Moffitt Cancer Research Center and Institute, 12902 Magnolia Dr., Tampa, FL 33612, USA. marilena.tauro@moffitt.org.
Abstract:
Bone metastatic breast cancer is currently incurable and will be evident in more than 70% of patients that succumb to the disease. Understanding the factors that contribute to the progression and metastasis of breast cancer can reveal therapeutic opportunities. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes whose role in cancer has been widely documented. They are capable of contributing to every step of the metastatic cascade, but enthusiasm for the use of MMP inhibition as a therapeutic approach has been dampened by the disappointing results of clinical trials conducted more than 20 years ago. Since the trials, our knowledge of MMP biology has expanded greatly. Combined with advances in the selective targeting of individual MMPs and the specific delivery of therapeutics to the tumor microenvironment, we may be on the verge of finally realizing the promise of MMP inhibition as a treatment strategy. Here, as a case in point, we focus specifically on MMP-2 as an example to show how it can contribute to each stage of breast-cancer-to-bone metastasis and also discuss novel approaches for the selective targeting of MMP-2 in the setting of the bone-cancer microenvironment.
Insights
Matrix metalloproteinases (MMPs) are key to breast cancer bone metastasis. New strategies targeting MMP-2 offer hope for treating this incurable disease by inhibiting cancer spread.
Area of Science:
- Oncology
- Biochemistry
- Cancer Metastasis
Background:
- Bone metastatic breast cancer is a prevalent and incurable condition, affecting over 70% of patients with advanced disease.
- Matrix metalloproteinases (MMPs) are enzymes implicated in cancer progression and metastasis, but early inhibition trials yielded disappointing results.
- Recent advancements in understanding MMP biology and targeted delivery offer renewed potential for MMP-targeted therapies.
Purpose of the Study:
- To elucidate the role of MMP-2 in each stage of breast cancer bone metastasis.
- To explore novel therapeutic strategies for selectively targeting MMP-2 within the bone-cancer microenvironment.
Main Methods:
- Review of existing literature on MMP biology and breast cancer bone metastasis.
- Focus on MMP-2 as a specific example of MMP involvement in metastasis.
- Discussion of emerging targeted therapeutic approaches for MMP-2.
Main Results:
- MMP-2 contributes significantly to the progression and metastasis of breast cancer to bone.
- Selective targeting of MMP-2 presents a promising therapeutic avenue.
Conclusions:
- Targeting MMP-2, particularly with advanced selective strategies, holds potential for treating bone metastatic breast cancer.
- Further research into MMP-2 inhibition within the bone microenvironment is warranted.
More Related Videos
08:11An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
12:23Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
Published on: August 14, 2012
Related Concept Videos
01:18The Bone Matrix
01:42The Extracellular Matrix
01:29The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:17Cut-off Frequency of BJT
Alpha Cut-Off Frequency: Pertinent to the common-base configuration, the alpha cut-off frequency defines the upper-frequency limit at which the current gain, alpha, remains stable. As...
01:08Brick Cutting Techniques
Cut bricks are categorized by size. Bricks cut to half their original length are called half-bats, while those cut to three-fourths their length are known as three-fourth bats.
Special types of...